Design and synthesis of pseudo-symmetric HIV protease inhibitors containing a novel hydroxymethylcarbonyl (HMC)-hydrazide isostere

被引:10
作者
Hidaka, K
Kimura, T
Hayashi, Y
McDaniel, KF
Dekhtyar, T
Colletti, L
Kiso, Y [1 ]
机构
[1] Kyoto Pharmaceut Univ, Dept Med Chem, Ctr Frontier Res Med Sci, Yamashima Ku, Kyoto 6078412, Japan
[2] Abbott Labs, Global Pharmaceut Res & Dev, Antiviral Res, Abbott Pk, IL 60064 USA
关键词
D O I
10.1016/S0960-894X(02)00848-X
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Pseudo-symmetric HIV-1 protease inhibitors containing a novel HMC-hydrazide isostere as the transition-state mimic were designed and synthesized. Most of the synthetic compounds with varied structures at the P and P' sites around this core unit showed potent inhibitory activity against HIV-1 protease with nanomolar K-i values. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:93 / 96
页数:4
相关论文
共 22 条
  • [1] New aza-dipeptide analogues as potent and orally absorbed HIV-1 protease inhibitors:: Candidates for clinical development
    Bold, G
    Fässler, A
    Capraro, HG
    Cozens, R
    Klimkait, T
    Lazdins, J
    Mestan, J
    Poncioni, B
    Rösel, J
    Stover, D
    Tintelnot-Blomley, M
    Acemoglu, F
    Beck, W
    Boss, E
    Eschbach, M
    Hürlimann, T
    Masso, E
    Roussel, S
    Ucci-Stoll, K
    Wyss, D
    Lang, R
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (18) : 3387 - 3401
  • [2] DESIGN, ACTIVITY, AND 2.8 A CRYSTAL-STRUCTURE OF A C2 SYMMETRICAL INHIBITOR COMPLEXED TO HIV-1 PROTEASE
    ERICKSON, J
    NEIDHART, DJ
    VANDRIE, J
    KEMPF, DJ
    WANG, XC
    NORBECK, DW
    PLATTNER, JJ
    RITTENHOUSE, JW
    TURON, M
    WIDEBURG, N
    KOHLBRENNER, WE
    SIMMER, R
    HELFRICH, R
    PAUL, DA
    KNIGGE, M
    [J]. SCIENCE, 1990, 249 (4968) : 527 - 533
  • [3] Aza-peptide analogs as potent human immunodeficiency virus type-1 protease inhibitors with oral bioavailability
    Fassler, A
    Bold, G
    Capraro, HG
    Cozens, R
    Mestan, J
    Poncioni, B
    Rosel, J
    TintelnotBlomley, M
    Lang, M
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (16) : 3203 - 3216
  • [4] ANTIVIRAL AND PHARMACOKINETIC PROPERTIES OF C2 SYMMETRICAL INHIBITORS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE
    KEMPF, DJ
    MARSH, KC
    PAUL, DA
    KNIGGE, MF
    NORBECK, DW
    KOHLBRENNER, WE
    CODACOVI, L
    VASAVANONDA, S
    BRYANT, P
    WANG, XC
    WIDEBURG, NE
    CLEMENT, JJ
    PLATTNER, JJ
    ERICKSON, J
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (11) : 2209 - 2214
  • [5] STRUCTURE-BASED, C2 SYMMETRICAL INHIBITORS OF HIV PROTEASE
    KEMPF, DJ
    NORBECK, DW
    CODACOVI, LM
    WANG, XC
    KOHLBRENNER, WE
    WIDEBURG, NE
    PAUL, DA
    KNIGGE, MF
    VASAVANONDA, S
    CRAIGKENNARD, A
    SALDIVAR, A
    ROSENBROOK, W
    CLEMENT, JJ
    PLATTNER, JJ
    ERICKSON, J
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (10) : 2687 - 2689
  • [6] Design and synthesis of a covalently linked HIV-1 protease dimer analog and peptidomimetic inhibitors
    Kiso, Y
    [J]. JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN, 1998, 56 (11) : 896 - 907
  • [7] Kiso Y, 1999, BIOPOLYMERS, V51, P59, DOI 10.1002/(SICI)1097-0282(1999)51:1<59::AID-BIP7>3.0.CO
  • [8] 2-3
  • [9] Kiso Y, 1998, ARCH PHARM, V331, P87, DOI 10.1002/(SICI)1521-4184(199803)331:3<87::AID-ARDP87>3.0.CO
  • [10] 2-H